Quadria, TPG eye up to 25% stake for $100 mn in Samarth Life Sciences

India’s pharmaceutical space has seen a flurry of deal-making activity over the last year as investors look to leverage the global supply chain diversification which has benefited the pharma and healthcare manufacturing sectors.